Procaps Group, an integrated LatAm healthcare and pharmaceutical conglomerate, agreed to acquire Grupo Somar, an integrated pharmaceutical company, from Advent International, one of the world’s largest private equity investors. Financial terms were not disclosed. "We are thrilled to execute an important milestone on our long-planned rollup strategy with an ideal acquisition target for Procaps. We believe Grupo Somar´s diversified portfolio of innovative products alongside its management and technical capabilities will help accelerate Procaps top and bottom-line growth into the near future in an accretive manner. With this acquisition, Procaps continues to diversify its products and geographies based on being a leader in innovative oral delivery systems. I´m excited to finally have a physical presence in Mexico, a country for which we have had great admiration for many years. This is something that we have been working towards for quite some time. This announcement marks an incredibly proud day in our company´s 45-year-old history. Procaps went public in September 2021 to make acquisitions just like this one," Ruben Minski, Procaps CEO.